Replies to post #80716 on Avid Bioservices Inc (CDMO)

[honestabe13]

mouse...

i wouldn't sell the analysts short.

everybody here, and those analysts, wants the science to succeed...for all the right humanistic reasons. i believe some of the pros feel that way, too, and that's a big part of why pphm has become well known among followers of biotech.

pphm needs to make a deal that says the science has value.

that deal must stop the dilution.

time is just about up for the longtimers.

[keep_trying]

FTM, if nothing else, the two analysts following PPHM have laid out a target price of $5 pps. That includes a recent update reflecting PPHM's NSCLC results. So, someone seeking to do a cheap buyout of PPHM will know that they are at least expected to put a $5 pps offer in play.

I expect that PPHM reporting of additional good trial results will see analyst one year outlook projections increasing. More good news keeps raising baseline pps expectations.

We shall see.

Best wishes and IMO.
KT